drug · small molecule
darinaparsin
Phase 2updated 3mo agoby Solasia Pharma KK🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for neoplasm and mature t-cell and nk-cell non-hodgkin lymphoma and 6 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying darinaparsin
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that